Sensitive Tenofovir Resistance Screening of HIV-1 From the Genital and Blood Compartments of Women With Breakthrough Infections in the CAPRISA 004 Tenofovir Gel Trial

The Centre for the AIDS Programme of Research in South Africa 004 (CAPRISA 004) study demonstrated that vaginally applied tenofovir gel is a promising intervention for protecting women from sexually acquiring human immunodeficiency virus (HIV). However, the potential for emergence of tenofovir resis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wei, Xierong, Hunt, Gillian, Abdool Karim, Salim S., Naranbhai, Vivek, Sibeko, Sengeziwe, Abdool Karim, Quarraisha, Li, Jin-fen, Kashuba, Angela D. M., Werner, Lise, Passmore, Jo-Ann S., Morris, Lynn, Heneine, Walid, Johnson, Jeffrey A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4038144/
https://ncbi.nlm.nih.gov/pubmed/24436453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars